Alissia Rosati

Alissia Rosati's work experience begins in 2010 as a Stagiaire in the Histology-Cytology department at the Department of Biomedical and Preclinical Sciences. Alissia then moves on to the GIGA-Neurosciences department in 2012, where they work as a Stagiaire. In 2013, Alissia becomes a Stagiaire researcher in the Department of Biomedical and Preclinical Sciences/GIGA-R: Human Genetics. Alissia joins GSK in 2017 as a QC Technician and continues in that role until January 2021. Currently, Alissia works as a Research Associate at BCI PHARMA, starting in January 2021.

Alissia Rosati has a Master's degree in Sciences biomédicales from the University of Liège, which they completed in 2013. In 2015, they obtained a Certificate of achievement from the EF Executive Language Institute for the EF Standard English Test. From an unspecified timeframe until 2016, they studied Les Gxp (GMP, GLP, GCP) et Medical Devices at GIGA-BIOPHARE Biowin. In 2016, Alissia attended Ulb-Biopark Formation where they specialized in 4 Cells, particularly in culture and cellular therapy (cell lines and stem cells).

Location

Seraing, Belgium

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


BCI PHARMA - We take care of your health

BCI Pharma is an innovative bio-pharmaceutical company focused on small molecule drug discovery. We design innovative chemical libraries and our HTS platform can support your owned library synthesis. Founded by : - Dr. Dominique Surleraux who was head of research for a pharmaceutical company (J&J) and two biotech companies (Idenix and Tibotec). - Dr. Elisabeth Picou who had a position in a hospital, treating patients with infectious diseases.